Yahoo Finance • 3 days ago
* Immatics N.V. (NASDAQ:IMTX [https://seekingalpha.com/symbol/IMTX]) has appointed Venkat Ramanan as chief financial officer, effective immediately. * Ramanan brings 25+ years of biopharma finance experience, with leadership roles at S... Full story
Yahoo Finance • 3 days ago
https://immatics.com/ Houston, Texas and Tuebingen, Germany, October 1, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, to... Full story
Yahoo Finance • 4 days ago
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best large cap value stocks to buy now. On September 22, Morgan Stanley analyst Terence Flynn maintained a Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD), keeping the associated price ta... Full story
Yahoo Finance • 4 days ago
[U.S. President Donald Trump Visits Scotland For Rounds Of Golf And Trade Talks] Christopher Furlong Announcing an agreement with Pfizer (NYSE:PFE [https://seekingalpha.com/symbol/PFE]) to offer all brand-name drugs marketed by the compan... Full story
Yahoo Finance • 5 days ago
[Donkey and Elephant Tug of War for the White House] JimLarkin Congress faces a critical deadline this week as the U.S. government edges closer to a potential shutdown. Lawmakers must reach a funding agreement by 12:01 a.m. Wednesday to a... Full story
Yahoo Finance • 6 days ago
We came across a bullish thesis on Biogen Inc. on Investing With Purpose’s Substack. In this article, we will summarize the bulls’ thesis on BIIB. Biogen Inc.'s share was trading at $143.81 as of September 18th. BIIB’s trailing and forwar... Full story
Yahoo Finance • 8 days ago
Gilead Sciences, Inc. (NASDAQ:GILD) ranks among the most undervalued NASDAQ stocks to buy now. Citing momentum in Gilead Sciences, Inc. (NASDAQ:GILD)’s product pipeline, Moody’s updated the company’s outlook from stable to positive on Sept... Full story
Yahoo Finance • 12 days ago
Pictured: Chris McDonald, newest member of Cellares' Board of Advisors Veteran operations leader, with experience at Amgen, Novartis, AstraZeneca, and Kite/Gilead brings decades of manufacturing, quality, and supply chain expertise to sup... Full story
Yahoo Finance • 12 days ago
Gilead Sciences recently broke ground on a 180,000-square-foot AI-enabled Pharmaceutical Development and Manufacturing Technical Development Center at its Foster City campus, part of a US$32 billion investment plan through 2030, and expand... Full story
Yahoo Finance • 15 days ago
[Senior man researching about medicine online] blackCAT/E+ via Getty Images * The Trump administration is said to be discussing the launch of a website that would allow consumers to purchase prescription drugs less expensively by buying... Full story
Yahoo Finance • 19 days ago
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the clos... Full story
Yahoo Finance • 19 days ago
Building Resilience and Innovation: California’s Pharmaceutical Renaissance California is quietly staging a pharmaceutical renaissance, not of arts or culture this time, but of science, supply chains, and life-changing therapies. As the b... Full story
Yahoo Finance • 19 days ago
Curious about the market action on Monday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. [gap] GAP DOWN STOCKS TICKER CHANGE COMMENT CTVA [https://www.chartmill... Full story
Yahoo Finance • 19 days ago
Below is Validea's guru fundamental report for GILEAD SCIENCES, INC. (GILD). Of the 22 guru strategies we follow, GILD rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy lo... Full story
Yahoo Finance • 21 days ago
In the world of investing, few strategies have shown as much lasting strength as value investing. This method, created by Benjamin Graham and made famous by Warren Buffett, focuses on finding stocks selling for less than their inherent wor... Full story
Yahoo Finance • 22 days ago
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Goosehead Insurance Inc (Symbol: GSHD), where a total of 2,556 contracts have traded so far, representing approximately 255,600 un... Full story
Yahoo Finance • 22 days ago
[Savings concept - Piggy bank on US nickel coins] PM Images This week's dividend activity included increased payouts from Royal Caribbean Cruises (RCL [https://seekingalpha.com/symbol/RCL]) and Argan (AGX [https://seekingalpha.com/symbol/... Full story
Yahoo Finance • 22 days ago
[New York Marks 24th Anniversary Of September 11 Terror Attacks] Michael M. Santiago/Getty Images News President Donald Trump is exerting pressure on major pharmaceutical companies to lower drug prices in the U.S. and wants them to commit... Full story
Yahoo Finance • 24 days ago
[Businesspeople making handshakes, while standing on painted pattern on asphalt] * Veeva Systems (NYSE:VEEV [https://seekingalpha.com/symbol/VEEV]) said that Gilead Sciences (NASDAQ:GILD [https://seekingalpha.com/symbol/GILD]) has partn... Full story
Yahoo Finance • 24 days ago
Next generation CRM with deep capabilities and agentic AI PLEASANTON, Calif., Sept. 10, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Gilead Sciences has committed to Veeva Vault CRM.Veeva Systems (PRNewsfoto/Veeva... Full story